Browsing Tag
XOMA Royalty Corporation
2 posts
Mural Oncology shareholders to receive fixed $2.035 per share as XOMA Royalty deal nears closing
Mural Oncology confirms a fixed $2.035 per share cash payout as its acquisition by XOMA Royalty nears closing, locking in a definitive exit for investors.
XOMA Royalty completes LAVA Therapeutics acquisition in push to strengthen bispecific antibody pipeline
Find out how XOMA Royalty’s acquisition of LAVA Therapeutics strengthens its oncology royalty portfolio and expands its partnered bispecific antibody programs.